The Children’s Tumor Foundation (CTF) Europe has been recognized as a ‘rising star’ at this year’s Boston CEO and Board of Director Conference, part of Biotech Week Boston. The award was announced at BioPharm America’s digital event highlighting innovation in biotech/biopharma, comprised of leading decision makers in the life sciences.
In making the announcement, Wendy Nelson, PhD, the CEO and President of Leading Biotech Boston said in presenting the award that “The Children’s Tumor Foundation has been in existence in United States for over 40 years, however CTF Europe was founded less than 2 years ago and has made incredible strides in raising visibility, forming a neurofibromatosis registry, forging partnerships, educating the community, and raising money for research”.
Accepting the award was Annette Bakker, PhD, President of the Children’s Tumor Foundation and Vice Chair of Children’s Tumor Foundation Europe. Annette thanked the event organizers and attendees on behalf of the neurofibromatosis (NF) community, and expressed confidence that investors and biotech leaders are increasingly recognizing patient advocacy groups like CTF as R&D accelerators, enabling needed advancements in disease research that will result in effective treatments for patients.
To learn more about Children’s Tumor Foundation Europe, visit ctfeurope.org.
To read about recent CTF Europe activities, read its most recent newsletter here.
